Anapong et al. jection (p=0.218). When compared among groups, the standing tolerance of one amount of stenosis DLS sufferers post-injection was significantly greater than the standing tolerance of two levels of stenosis DLS individuals (p0.001) as shown in Fig. 4.Asian Spine J 2014;8(two):119-128 The walking tolerance of a single of level stenosis DLS individuals post-injection at two weeks was significantly greater than pre-injection (p0.012) when in two levels of stenosis DLS patients, there were no considerable differences from the walking tolerance in between pre-injection and post-3.5 3 two.5 two 1.5 1 0.5Means of Roland 5-point pain scaleStenosis 1 level Stenosis 2 levelsPre-injection2 wk6 wk3 mo12 moFig. three. Line graph displaying the Roland 5-point pain scale of 1 amount of stenosis DLS sufferers and two levels of stenosis DLS individuals over time. There was a significant difference (p =0.004) amongst these two groups. DLS, lumbar spondylolisthesis.three.5Means of standing tolerance2.5 two 1.5 1 0.5Stenosis 1 level Stenosis 2 levelsPre-injection2 wk6 wk3 mo12 moFig. four. Line graph showing standing tolerance of one amount of stenosis DLS sufferers and two levels of stenosis DLS sufferers over time. There was a significant difference (p 0.001) involving these two groups. DLS, lumbar spondylolisthesis.Asian Spine Journalinjection (p=0.510). When compared between groups, the walking tolerance of 1 amount of stenosis DLS patients post-injection was drastically larger than the walking tolerance of two levels of stenosis DLS patients (p0.001) as shown in Fig. five.Outcomes of fluoroscopically guided 125 There have been no substantial variations on the patient satisfaction scale post-injection of both groups (p=0.2072 and p=0.023, respectively); except at 12 months, when the patient satisfaction scale was significantly reduce than at two weeks (p0.05). When compared amongst groups, there3 2.Means of walking tolerance2 1.five 1 0.Ethyl 4-methylpent-4-enoate In stock five 0 Stenosis 1 level Stenosis 2 levelsPre-injection2 wk6 wk3 mo12 moFig.287944-16-5 Purity 5. Line graph displaying walking tolerance of a single amount of stenosis DLS sufferers and two levels of stenosis DLS sufferers over time.PMID:24455443 There was a considerable distinction (p 0.001) amongst these two groups. DLS, lumbar spondylolisthesis.four.Indicates of patient satisfaction scale4 three.five three 2.five two 1.five 1 0.5 0 two wk six wk three mo 12 mo Stenosis 1 level Stenosis two levelsFig. 6. Line graph showing the patient satisfaction scale of one particular level of stenosis DLS patients and two levels of stenosis DLS sufferers more than time. There was no substantial distinction (p =0.058) between these two groups. DLS, lumbar spondylolisthesis.126 Chaiwat Kraiwattanapong et al. was no substantial distinction within the patient satisfaction scale between both groups as shown in Fig. six.Asian Spine J 2014;eight(2):119-128 outcomes as pointed out above, we decided to use the TFESI technique for this study. The outcomes from our study showed that, TFESI considerably lowered VAS and Roland 5-point discomfort scores for both quick term and long term adhere to ups. Nonetheless, standing tolerance and walking tolerance only substantially improved inside the short term (for 2 weeks), but within the long-term there was no significant difference. The patient satisfaction scale for this procedure was highest at 2 weeks and declined with time. These final results could be explained by the many issues within the pathology of DLS as previously described. Corticosteroid has direct anesthetic effects by blocking the nociceptive c-fiber conduction as well as inhibits phospholipase A2 activity which can be fou.